Fig. 3
From: Bone marrow-derived Ly6C− macrophages promote ischemia-induced chronic kidney disease

Ly6C−macrophages, which are the dominant macrophages in WT kidneys in CKD after I/R injury, are mostly CX3CR1+, derived from bone marrow and incapable of differentiating into α-SMA+cells. a The percentage (left) and number (right) of Ly6C− and Ly6C+ macrophage analyses by flow cytometry from whole kidneys in WT mice. b The analyses by flow cytometry of percentage of CX3CR1+ and CX3CR1− macrophages in WT kidneys at d7 after I/R gated on F4/80+Ly6C−. Graphs and representative plots. c Scheme of bone marrow chimera. d The percentage of GFP− and GFP+ cells among Ly6C− macrophage analyses by flow cytometry from the peripheral blood (left) and kidneys (right) of bone marrow chimeric mice at d10/d20 after I/R. Graphs and representative plots. e The analyses by flow cytometry of the percentage (middle) and number (right) of α-SMA+ and α-SMA− cells among Ly6C−GFP+ macrophages from kidneys of bone marrow chimeric mice at d10/20 after I/R. Graphs and representative plots. Scale bars,100 μm. N = 4–6/group. n.s. P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001. Values were means±SD. Mø, macrophages. BMC, bone marrow chimera